Reduced levels of VDAC1 and phosphorylated tau may maintain normal mitochondrial pore opening and pore closure, ultimately leading to normal mitochondrial function, mitochondria supplying ATP to nerve terminals, and boosting synaptic and cognitive function in AD (Manczak and Reddy, 2012b). Here, MAPT is linked to Alzheimer disease.